Entering the era of precision medicine to treat amyotrophic lateral sclerosis
Abstract With the disease modifying therapy Qalsody (tofersen) which targets the RNA product of the SOD1 gene, having been shown effective in amyotrophic lateral sclerosis (ALS), the present perspective seeks to explore progress towards the implementation of precision medicine principles in ALS drug...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-10-01
|
| Serier: | Molecular Neurodegeneration |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13024-025-00890-5 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
